PACIRA BIOSCIENCES, INC. Income Taxes Paid
PACIRA BIOSCIENCES, INC. (PCRX) reported Income Taxes Paid of $910.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2026-06-30 was $860.00K, a 89.18% decline year-over-year.
- PACIRA BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2026-03-31 was $50.00K, a 82.52% decline year-over-year.
- PACIRA BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2025-12-31 was $69.00K, a 95.16% decline year-over-year.
- PACIRA BIOSCIENCES, INC. income taxes paid, net for the quarter ending 2025-09-30 was $711.00K, a 85.51% decline year-over-year.
- PACIRA BIOSCIENCES, INC. income taxes paid, net for fiscal 2025 was $9.01M, a 18.06% decline from fiscal 2024.
- PACIRA BIOSCIENCES, INC. income taxes paid, net for fiscal 2024 was $11.00M, a 150.00% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. income taxes paid, net for fiscal 2023 was $4.40M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $860.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $910.00K 10-Q · filed 2026-08-04 | $979.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.69M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $50.00K 10-Q · filed 2026-04-30 | $119.00K derived: sum of 2 quarters · filed 2026-04-30 | $830.00K derived: sum of 3 quarters · filed 2026-04-30 | $8.78M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $780.00K derived: sum of 2 quarters · filed 2026-02-26 | $8.73M derived: sum of 3 quarters · filed 2026-08-04 | $9.01M 10-K · filed 2026-02-26 |
| 2025-09-30 | $711.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.66M derived: sum of 2 quarters · filed 2026-08-04 | $8.94M 10-Q · filed 2025-11-06 | $10.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $7.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.23M 10-Q · filed 2026-08-04 | $9.66M derived: sum of 3 quarters · filed 2026-08-04 | $14.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $286.00K 10-Q · filed 2026-04-30 | $1.71M derived: sum of 2 quarters · filed 2026-04-30 | $6.62M derived: sum of 3 quarters · filed 2026-04-30 | $11.53M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.33M derived: sum of 2 quarters · filed 2026-02-26 | $11.24M derived: sum of 3 quarters · filed 2026-02-26 | $11.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.82M derived: sum of 2 quarters · filed 2025-11-06 | $9.57M 10-Q · filed 2025-11-06 | $11.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $4.67M 10-Q · filed 2025-08-05 | $7.00M derived: sum of 3 quarters · filed 2026-02-26 | $8.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$245.00K 10-Q · filed 2025-05-08 | $2.08M derived: sum of 2 quarters · filed 2026-02-26 | $3.36M derived: sum of 3 quarters · filed 2026-02-26 | $3.95M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.60M derived: sum of 2 quarters · filed 2026-02-26 | $4.20M derived: sum of 3 quarters · filed 2026-02-26 | $4.40M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.87M derived: sum of 2 quarters · filed 2024-11-06 | $2.07M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $795.00K 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $201.00K 10-Q · filed 2024-05-07 | |||
| 2022-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.21M derived: sum of 2 quarters · filed 2023-11-02 | $4.22M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $4.10M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-03 | |||
| 2021-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.26M derived: sum of 2 quarters · filed 2022-11-03 | $2.26M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.45M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-04 | |||
| 2020-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.33M derived: sum of 2 quarters · filed 2021-11-03 | $2.33M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $80.00K 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | |||
| 2019-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $702.00K 10-Q · filed 2020-10-30 | ||
| 2019-06-30 | $490.00K 10-Q · filed 2020-08-06 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $146.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $146.00K 10-Q · filed 2019-08-08 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $133.00K derived: sum of 2 quarters · filed 2018-11-01 | $133.00K 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $133.00K 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2016-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $111.00K derived: sum of 2 quarters · filed 2017-11-08 | $253.00K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $241.00K 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $142.00K 10-Q · filed 2017-05-04 | |||
| 2015-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $39.00K derived: sum of 2 quarters · filed 2016-11-02 | $199.00K 10-Q · filed 2016-11-02 | |
| 2015-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $159.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $160.00K 10-Q · filed 2016-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |